Vai al contenuto principale della pagina

Advances in cancer drug targets . Volume 1 / / editor, Atta-ur-Rahman



(Visualizza in formato marc)    (Visualizza in BIBFRAME)

Titolo: Advances in cancer drug targets . Volume 1 / / editor, Atta-ur-Rahman Visualizza cluster
Pubblicazione: Sharjah, United Arab Emirates ; ; Oak Park, Ill., : Bentham Science Publishers, [2013?]
Edizione: 1st ed.
Descrizione fisica: 1 online resource (316 p.)
Disciplina: 615/.19
Soggetto topico: Cancer - Chemotherapy
Drug targeting
Altri autori: RahmanAtta-ur- <1942->  
Note generali: Description based upon print version of record.
Nota di bibliografia: Includes bibliographical references and index.
Nota di contenuto: Title; EUL; Contents; Foreword; List of Contributors; Chapter 01; Chapter 02; Chapter 03; Chapter 04; Chapter 05; Chapter 06; Chapter 07; Chapter 08; Index
Sommario/riassunto: Advances in Cancer Drug Targets is an e-book series that brings together recent expert reviews published on the subject with a focus on strategies for synthesizing and isolating organic compounds and elucidating the structure and nature of DNA. The reference work serves to give readers a brief yet comprehensive glance at current theory and practice behind employing chemical compounds for tackling tumor suppression, DNA site specific drug targeting and the inhibition of enzymes involved in growth control pathways. The reviews presented in this series are written by experts in pharmaceutical sciences and molecular biology. These reviews have been carefully selected to present development of new approaches to anti-cancer therapy and anti-cancer drug development. This e-book volume will be of special interest to molecular biologists and pharmaceutical scientists.
Titolo autorizzato: Advances in cancer drug targets  Visualizza cluster
ISBN: 1-60805-474-8
Formato: Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione: Inglese
Record Nr.: 9910814601403321
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Serie: Advances in Cancer Drug Targets